Concepedia

J.W. Nawrocki

JN

Statistics

Publications

4

Citations

703

H-Index

4

Active since

1983

Affiliations

Gaertner (United States)(Current)

J.W. Nawrocki is an author at Gaertner (United States) specializing in lipid-lowering therapy, plasma cholesterol levels, and cholesterol metabolism.

Publications per year

1983–1998

4

Publications

4

Reduction of LDL Cholesterol by 25% to 60% in Patients With Primary Hypercholesterolemia by Atorvastatin, a New HMG-CoA Reductase Inhibitor

J.W. Nawrocki, Stuart Weiss, Michael H. Davidson et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1995 · 486 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

An Overview of the Clinical Safety Profile of Atorvastatin (Lipitor), a New HMG-CoA Reductase Inhibitor

Donald M. Black, Rebecca Bakker‐Arkema, J.W. Nawrocki · Archives of Internal Medicine · 1998 · 163 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Some comparative effects of gemfibrozil, clofibrate, bezafibrate, cholestyramine and compactin on sterol metabolism in rats

Richard E. Maxwell, J.W. Nawrocki, Paul D. Uhlendorf · Atherosclerosis · 1983 · 32 citations

Life Sciences, Biochemistry, Pharmacology +10

A study to determine the response of coronary atherosclerosis to raising low high density lipoprotein cholesterol with a fibric-acid derivative in men after coronary bypass surgery

Mikko Syvänne, Marja‐Riitta Taskinen, Markku S. Nieminen et al. · Controlled Clinical Trials · 1997 · 22 citations

Medicine, Cardiology, Surgery +16

1–4 of 4